Luke Miels
Directeur Général chez
GSK PLC
Fortune : 10 M $ au 31/08/2026
Profil
Luke Victor Miels is currently Chief Executive Officer & Executive Director at GSK Plc since 2026, Director at ViiV Healthcare Co., and Member of the Singapore Economic Development Board.
Former roles include Executive VP-Global Portfolio & Product Strategy at AstraZeneca PLC and Regional VP-Asia Pacific & Pharmaceuticals Division at Roche Pharmaceuticals, Inc. Education includes an MBA from Macquarie University and undergraduate studies at Flinders University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
GSK PLC 0,01 % | 10/07/2026 | 413 119 ( 0,01 % ) | 10 M $ | 31/08/2026 |
Dernières actualités sur Luke Miels
Postes actifs de Luke Miels
| Sociétés | Poste | Début |
|---|---|---|
| GSK PLC | Directeur Général | 01/01/2026 |
ViiV Healthcare Co.
 ViiV Healthcare Co. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, ViiV Healthcare is a pharmaceutical company that specializes in HIV medicines and research, with a focus on people living with HIV and AIDS. The company is based in Raleigh, NC. The company is committed to finding new ways to treat, prevent, and ultimately find a cure for HIV, while also focusing on bridging the gap between research and clinical practice through implementation science and patient-centered studies. ViiV Healthcare takes a holistic approach to developing new medicines and supporting sustainable community programs for the HIV community. The company's scientists have been at the forefront of developing innovative HIV medicines since the start of the HIV and AIDS epidemic. ViiV Exchange is a platform that provides healthcare professionals with access to product information, clinical data, publications, webcasts, and medical education related to HIV. The company is dedicated to treating, preventing, and eventually curing HIV. | Directeur/Membre du Conseil | - |
Singapore Economic Development Board
 Singapore Economic Development Board General GovernmentGovernment Provides plans and excutives ecomomic strategies | Corporate Officer/Principal | - |
Anciens postes connus de Luke Miels
| Sociétés | Poste | Fin |
|---|---|---|
| ASTRAZENECA PLC | Corporate Officer/Principal | 01/01/2017 |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Corporate Officer/Principal | - |
Formation de Luke Miels
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
83
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Commercial Services |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Singapore Economic Development Board
Singapore Economic Development Board General GovernmentGovernment Provides plans and excutives ecomomic strategies | Government |
Macquarie University
 Macquarie University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Flinders University
 Flinders University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ViiV Healthcare Co.
ViiV Healthcare Co. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, ViiV Healthcare is a pharmaceutical company that specializes in HIV medicines and research, with a focus on people living with HIV and AIDS. The company is based in Raleigh, NC. The company is committed to finding new ways to treat, prevent, and ultimately find a cure for HIV, while also focusing on bridging the gap between research and clinical practice through implementation science and patient-centered studies. ViiV Healthcare takes a holistic approach to developing new medicines and supporting sustainable community programs for the HIV community. The company's scientists have been at the forefront of developing innovative HIV medicines since the start of the HIV and AIDS epidemic. ViiV Exchange is a platform that provides healthcare professionals with access to product information, clinical data, publications, webcasts, and medical education related to HIV. The company is dedicated to treating, preventing, and eventually curing HIV. | Health Technology |
